Form 4: Plexus CFO Sells 1,998 Shares Under 10b5-1 Plan
Insider Transaction Report
Plexus Corp.'s Executive VP & CFO, Patrick John Jermain, sold 1,998 shares of common stock for $142.8 per share on October 27, 2025, under a pre-arranged 10b5-1 plan.
Summary
- Patrick John Jermain, Executive VP & CFO of Plexus Corp. (PLXS), reported a transaction involving the company's common stock.
- On October 27, 2025, Jermain sold 1,998 shares of Plexus Corp. common stock.
- The shares were sold at a price of $142.8 per share, totaling approximately $285,314.40.
- This transaction was executed pursuant to a Rule 10b5-1(c) contract, instruction, or written plan, indicating it was pre-scheduled.
- Following this sale, Jermain directly beneficially owns 18,961 shares of Plexus Corp. common stock.
- Additionally, Jermain indirectly holds 3,719 shares in the Plexus Corp. 401(k) Retirement Plan.
Sentiment
Score: 5
Explanation: Neutral. While insider selling can be viewed with caution, the transaction was pre-scheduled under a Rule 10b5-1 plan, which mitigates concerns about opportunistic selling based on non-public information. It represents a routine executive financial management activity.
Positives
- The sale was conducted under a Rule 10b5-1 plan, which suggests the transaction was pre-scheduled and not based on immediate, non-public information, enhancing transparency.
Negatives
- Insider selling, even under a 10b5-1 plan, can sometimes be perceived negatively by investors as it reduces management's direct equity stake in the company.
Future Outlook
NA
Industry Context
NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Policy Adherence | The transaction was executed under a Rule 10b5-1(c) plan, which allows insiders to set up a pre-arranged plan to buy or sell company stock to avoid accusations of insider trading. | 10/27/2025 | This demonstrates adherence to corporate governance best practices regarding insider trading, providing an affirmative defense against potential allegations and enhancing transparency around executive stock transactions. |
Stakeholder Impact
- Shareholders: May observe the reduction in direct insider ownership, though the 10b5-1 plan context typically lessens negative interpretations compared to unscheduled sales.
Key Dates
| Date | Description |
|---|---|
| 10/27/2025 | Date of common stock transaction (sale). |
| 10/29/2025 | Date of filing of the Statement of Changes in Beneficial Ownership. |
Keywords
Plexus Corp, PLXS, Insider Trading, Form 4, Stock Sale, Executive Compensation, Patrick John Jermain, CFO, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.